SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001601485-21-000036
Filing Date
2021-07-20
Accepted
2021-07-20 17:58:57
Documents
1
Period of Report
2021-07-14

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_162681832131836.html 4/A  
1 FORM 4/A wf-form4a_162681832131836.xml 4/A 2738
  Complete submission text file 0001601485-21-000036.txt   4138
Mailing Address C/O ADAMAS PHARMACEUTICALS INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address
Rhodes Jennifer J (Reporting) CIK: 0001568249 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39990 | Film No.: 211102103

Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations